STUDIES ON AMINO GROUP TERMINATED POLY(ETHER_URETHANE_AMIDE) LIGAND AND MAGNETIC RESONANCEIMAGING CONTRAST AGENT
Song Chunmei,Xue Haili,Ll Jianqi,Yu Yihua,Peng Min,Chen Qun,Qian Min,Xie Meiran,Du Bing
DOI: https://doi.org/10.3724/sp.j.1105.2009.00278
2009-01-01
Abstract:To develop and characterize a new class of potential blood pool magnetic resonance (MR) contrast agents which could be used as cancer target gene delivery carrier, novel gadolinium amino group terminated poly(etherurethane-amide) /diethylenetriamine pentaacetic acid (PEU-Gd-DTPA) polymeric chelate(IV) was synthesized. The amino group terminated poly(ether-urethane-amide)/diethylenetriamine pentaacetic acid (PEU/DTPA) copolymer ligand (III) could be designed and obtained from the reaction of diethylenetriamine pentaacetic acid dianhydride (DTPAA, I) with amino group terminated PEU (PEU-((CH(2))(6)NH(2))(2)) (II) which was prepared in high yield by the reaction of polyethylene glycol ( PEG) with isophorone dilsocyanate (IPDI) and then with hexamethylene diamine. Ligand III was then coordinated with Gd(3+) ion to give the macromolecular contrast agent W in water at room temperature. The structure analysis and characterization of DTPAA, U, HI were studied by IR, NMR, GPC, and functional group titration methods. Gadolinium content of the polymeric chelate IV was 0.88 wt%, which was determined by radio frequency inductively coupled plasma (ICP) spectra. In vitro relaxivity (R(1)) studies of IV showed a 38.40% increase in R, relaxivity compared with gadolinium-diethylenetriamine pentaacetic acid dimeglumine (Gd-DTPA) injection. The R, values for Gd-DTPA and IV were 5.93 and 8.21 (mmol/L)(-1) . s(-1), respectively. la vivo distribution of Gd-DTPA and IV was studied at magnetic resonance imaging (MRI) before injection, 0. 1 6, 12 and 24 h after injection, with assessment of liver signal intensity (SI) in 10 nude mice. The liver signal enhancement rates of IV at 0.1, 6, 12 and 24 h are 1.5, 3, 1.8 and 1.3 times, respectively, compared with the largest signal intensity 0.33 of Gd-DTPA observed at 0. 1 h. The half-life of IV in liver was as longer as 24 h, while no signal enhancement was observed after 6 hours injection of Gd-DTPA. IV had also a longer circulation life.